Search results
Found 184 matches for
Oxford, UK: 23 May, 2018: Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing. The round was led by Oxford Sciences Innovation who were joined by new investors RT Ventures, Borealis Ventures, Perivoli Innovations, along with further investment from all existing investors and Oxford University. Additionally, Borealis Managing Partner Phil Ferneau and Oxford Investment Consultants’ Partner James Mallinson join Orbit’s Board of Directors.
AVIC Symposium - 2017
Research
Thursday, 23 November 2017, 9.50am to 5pm
We would like to invite you to a one day symposium on acute vascular disease at the Richard Doll Building on Thursday 23rd November 2017. The day will consist of neuro and cardiac themed talks that span development / validation and applications in clinical research.